ADP |
adenosine diphosphate |
CTLA4 |
cytotoxic T-lymphocyte-associated protein 4 |
CRC |
colorectal cancer |
dMMR |
deficient mismatch repair |
EC |
endometrial cancers |
ESGO |
European Society of Gynaecological Oncology |
ESMO |
European Society for Medical Oncology |
ESTRO |
European Society for Radiotherapy and Oncology |
FIGO |
Federation of Gynecology and Obstetrics |
HGSC |
High-grade serous carcinoma |
HNPCC |
Hereditary Non-Polyposis Colorectal Cancer |
IHC |
immunohistochemistry |
LS |
Lynch syndrome |
LVSI |
lymphovascular space invasion |
MMR |
mismatch repair |
MSI |
microsatellite instable |
MSS |
microsatellite stable |
NGS |
next generation sequencing |
NSMP |
non specific molecular profile |
OC |
ovarian cancer |
PARP |
poly ADP ribose polymerase |
PCR |
polymerase chain reaction |
PD-1 |
program death 1 |
PD-L1 |
program death ligand 1 |
pMMR |
proficient mismatch repair |
POLE |
polymerase ε |
ProMisE |
Proactive Molecular Risk Classifier for Endometrial Cancer |